Oral urea has been used in the past to treat various diseases like gastric ulcers, liver metastases, sickle cell disease, heart failure, brain oedema, glaucoma, Meniere disease, etc. We have demonstrated for years, the efficacy of urea to treat euvolemic (SIADH) or hypervolemic hyponatremia. We briefly describe the indications of urea use in symptomatic and paucisymptomatic hyponatremic patients. Urea is a non-toxic, cheap product, and protects against osmotic demyelinating syndrome (ODS) in experimental studies. Prospective studies showing the benefit to treat mild chronic hyponatremia due to SIADH and comparing water restriction, urea, high ceiling diuretics, and antivasopressin antagonist antagonist should be done.SCOPUS: ar.jSCOPUS: ar....
Treatment options for chronic SIADH include water restriction (WR) and urea. The usefulness of urine...
Urea is recommended in the 2nd line treatment in moderate to severe hyponatraemia induced by syndrom...
Two vasopressin antagonists (vaptans) are now in the market for the treatment of euvolemic (Europe) ...
Oral urea has been used in the past to treat various diseases like gastric ulcers, liver metastases,...
Hyponatremia is the main complication of inappropriate antidiuretic hormone secretion (SIADH), somet...
Objective: Hyponatraemia in hospitalized patients is common and associated with increased mortality....
Introduction: Hyponatremia in the intensive care unit (ICU) is most commonly related to inappropriat...
BACKGROUND: Hyponatraemia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH...
Hyponatremia is the main complication of inappropriate antidiuretic hormone secretion (SIADH), somet...
Background Hyponatremia occurring as a result of the syndrome of inappropriate antidiuretic hormone ...
Hyponatremia is a common electrolyte disorder that carries significant morbidity and mortality. Howe...
Background: Treatment options for chronic SIADH include water restriction (WR) and urea. The usefuln...
textabstractThe treatment of hyponatraemia due to SIADH is not always as straightforward as it seems...
Introduction: Hyponatremia is the most common fluid and electrolyte abnormality. It is associated wi...
Hyponatremia is the most frequent electrolyte disorder and the syndrome of inappropriate antidiureti...
Treatment options for chronic SIADH include water restriction (WR) and urea. The usefulness of urine...
Urea is recommended in the 2nd line treatment in moderate to severe hyponatraemia induced by syndrom...
Two vasopressin antagonists (vaptans) are now in the market for the treatment of euvolemic (Europe) ...
Oral urea has been used in the past to treat various diseases like gastric ulcers, liver metastases,...
Hyponatremia is the main complication of inappropriate antidiuretic hormone secretion (SIADH), somet...
Objective: Hyponatraemia in hospitalized patients is common and associated with increased mortality....
Introduction: Hyponatremia in the intensive care unit (ICU) is most commonly related to inappropriat...
BACKGROUND: Hyponatraemia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH...
Hyponatremia is the main complication of inappropriate antidiuretic hormone secretion (SIADH), somet...
Background Hyponatremia occurring as a result of the syndrome of inappropriate antidiuretic hormone ...
Hyponatremia is a common electrolyte disorder that carries significant morbidity and mortality. Howe...
Background: Treatment options for chronic SIADH include water restriction (WR) and urea. The usefuln...
textabstractThe treatment of hyponatraemia due to SIADH is not always as straightforward as it seems...
Introduction: Hyponatremia is the most common fluid and electrolyte abnormality. It is associated wi...
Hyponatremia is the most frequent electrolyte disorder and the syndrome of inappropriate antidiureti...
Treatment options for chronic SIADH include water restriction (WR) and urea. The usefulness of urine...
Urea is recommended in the 2nd line treatment in moderate to severe hyponatraemia induced by syndrom...
Two vasopressin antagonists (vaptans) are now in the market for the treatment of euvolemic (Europe) ...